KOVALTRY
BAYER INC
Quick answers
Is there a shortage of KOVALTRY in Canada?
No. There is no current shortage of KOVALTRY 500UNIT reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
KOGENATE PWS 500IU/VIAL
MILES INC. - PHARMACEUTICAL DIVISION
RECOMBINATE PWS INJ 500I.U./VIAL
BAXTER HEALTHCARE CORPORATION
KOGENATE - PWS IV 500I.U./VIAL
BAYER CORPORATION
ADYNOVATE
TAKEDA CANADA INC
Other Products
RECOMBINATE PWS INJ 250I.U./VIAL
BAXTER HEALTHCARE CORPORATION
DIN
02451468
Strength
500UNIT
Dosage Form
Powder For Solution
Route
Intravenous
Active Ingredient
ANTIHEMOPHILIC FACTOR (RECOMBINANT)
See all ANTIHEMOPHILIC FACTOR (RECOMBINANT) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BAYER INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
60MG · DIN 02155990
20MG · DIN 02237618
30MG · DIN 02155907
0.5MG · DIN 02412764
2MG · DIN 02412802
2.5MG · DIN 02412810
1MG · DIN 02412772
1.5MG · DIN 02412799
5MG · DIN 02243919
0.5MG · DIN 02247193
DIN 02309300
220MG · DIN 02436337